Detalhe da pesquisa
1.
Bone and Joint Tissue Penetration of the Staphylococcus-Selective Antibiotic Afabicin in Patients Undergoing Elective Hip Replacement Surgery.
Antimicrob Agents Chemother
; 63(3)2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559136
2.
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Clin Cancer Res
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771739
3.
The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.
Hepatology
; 49(5): 1460-8, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19353740
4.
The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.
Hepatology
; 47(3): 817-26, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18302285
5.
A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations.
Clin Cancer Res
; 25(9): 2699-2707, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745300
6.
The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans.
Clin Pharmacol Drug Dev
; 4(1): 25-32, 2015 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27128001
7.
Pharmacological control of cellular calcium handling in dystrophic skeletal muscle.
Neuromuscul Disord
; 12 Suppl 1: S155-61, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12206810
8.
An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis C.
Expert Opin Investig Drugs
; 18(2): 211-20, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19236267